Telix Pharmaceuticals Market Cap

Telix Pharmaceuticals has a market cap or net worth of $6.33 billion as of February 21, 2025. Its market cap has increased by 152.55% in one year.

Market Cap

6.33B

Enterprise Value

6.25B

Revenue

484.69M

Ranking

n/a

PE Ratio

204.85

Stock Price

$18.90

Market Cap Chart

Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 115.28M to 6.33B, an increase of 5,389.71%. That is a compound annual growth rate of 73.44%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	6.33B	24.14%
Dec 31, 2024	5.10B	129.18%
Dec 29, 2023	2.22B	42.30%
Dec 30, 2022	1.56B	-2.70%
Dec 31, 2021	1.61B	96.45%
Dec 31, 2020	817.72M	196.48%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	2.16B
SS Innovations International	1.72B
Nika Pharmaceuticals	1.02B
Veradigm	919.08M
Elite Pharmaceuticals	509.35M
Glass House Brands	488.30M
Northwest Biotherapeutics	333.35M
CytoDyn	290.99M

Market Cap Rankings